Tumor-Associated Trypsin Inhibitor

Background and Aim: Chronic pancreatitis and pancreatic ductal adenocarcinoma (PDA) frequently overexpress epidermal growth… Expand

Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Colorectal cancer (CRC) is one of the most serious… Expand

Serine protease inhibitor Kazal type 1 (SPINK1) was originally identified as a trypsin inhibitor by Kazal et al. in 1948. SPINK1… Expand

Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Serine protease inhibitor Kazal type 1 (SPINK1… Expand

After the discovery of estrogen receptor beta (ERβ) in 1995, it became clear that in many “non-classical” estrogen-responsive… Expand

 

Chromogranin A (CGA) is a low MW (49,000) acidic hydrophilic protein. It is synthesized in the chromaffm granules of the… Expand

TATI (tumor associated trypsin inhibitor) is a low molecular weight protein employed as a tumor marker. To evaluate the role of… Expand

189 clinical and serological examinations were performed in 30 patients before treatment and during follow up of squamous cell… Expand

CA 125, CA 50 and Tumor Associated Trypsin Inhibitor (TATI) levels were assayed in blood samples drawn at diagnosis from 149… Expand